Related Experiment Video

Updated: Oct 17, 2025

Characterization and Functional Prediction of Bacteria in Ovarian Tissues
10:12

Characterization and Functional Prediction of Bacteria in Ovarian Tissues

Published on: October 23, 2021

3.0K

Gut bacteria enable prostate cancer growth

John A McCulloch1,2, Giorgio Trinchieri3

  • 1Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Science (New York, N.Y.)
|October 7, 2021
PubMed

Insights

Certain gut bacteria that produce testosterone can cause resistance to medical treatments. Understanding this link is crucial for developing more effective therapies against such conditions.

Area of Science:

  • Microbiology
  • Endocrinology
  • Oncology

Background:

  • Gut microbiota plays a significant role in host metabolism and disease.
  • Therapeutic resistance is a major challenge in treating various diseases, including cancer.
  • Testosterone's influence on cellular processes is well-documented, but its direct link to gut microbiota and therapy resistance is less understood.

Purpose of the Study:

  • To investigate the role of testosterone-synthesizing gut bacteria in mediating resistance to therapies.
  • To identify specific bacterial species involved in testosterone synthesis within the gut.
  • To explore the mechanisms by which these bacteria contribute to treatment failure.

Main Methods:

  • 16S rRNA gene sequencing and shotgun metagenomics to profile gut microbial communities.
  • Quantitative PCR (qPCR) and targeted gene sequencing to detect testosterone-synthesizing enzymes in bacteria.
  • In vitro and in vivo models to assess the impact of specific bacteria on therapeutic efficacy.

Main Results:

  • Identification of specific gut bacterial species capable of synthesizing testosterone.
  • Demonstration that the presence of these testosterone-synthesizing bacteria correlates with reduced sensitivity to certain therapies.
  • Evidence suggesting that bacterial testosterone production directly influences the tumor microenvironment and drug metabolism.

Conclusions:

  • Testosterone-synthesizing gut bacteria represent a novel mechanism driving therapeutic resistance.
  • Targeting these specific bacteria or their testosterone-producing pathways could be a promising strategy to overcome treatment resistance.
  • Further research is warranted to explore the clinical implications of the gut microbiome's endocrine function in treatment outcomes.

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.3K
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

10.8K

Related Concept Videos

Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
754
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
2.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K